Introduction
============

Since ancient times, China has been well known for its tasty food. There are large differences in the dietary habit among different regions in China due to large population, vast territory and different nationalities ([@b1-ol-0-0-10526]--[@b3-ol-0-0-10526]), which greatly enriches material life. However, the extremely complicated dietary habits also lead to high incidence rate of diet-related diseases, of which oral carcinoma is a malignant tumor with a high incidence rate, mainly oral squamous cell carcinoma (OSCC) in China ([@b4-ol-0-0-10526],[@b5-ol-0-0-10526]).

According to statistical data, OSCC accounts for more than 90% of oral carcinoma, so enhancing the research on OSCC has important theoretical and practical significance in China. Currently, the operation, including radiotherapy and chemotherapy, is dominated in the treatment of OSCC. However, metastasis occurs more easily in OSCC cells than general tumor cells, so there is no effective treatment method at present ([@b6-ol-0-0-10526],[@b7-ol-0-0-10526]). In recent years, related studies have found that the phosphatase and tensin homolog deleted on chromosome ten (PTEN) has close correlations with the incidence of a variety of tumors, including breast cancer and melanoma, and its expression declines obviously in the above tumor cells ([@b8-ol-0-0-10526],[@b9-ol-0-0-10526]).

On this basis, the present study investigated whether there is a correlation between PTEN gene and OSCC, and further explored whether there is also a correlation between PTEN gene polymorphism and OSCC, aiming to provide a certain theoretical and experimental basis for the treatment of OSCC.

Patients and methods
====================

### General data

In the experiment, 33 OSCC patients treated in the Affiliated Hospital of Taishan Medical University (Taian, China) from January 2016 to January 2018 were selected as the experimental group, including 18 males and 15 females, aged 45 years on average, while 33 healthy subjects were selected as the control group, including 17 males and 16 females, aged 45 years on average. The experimental scheme was discussed and approved by the Academic Committee, and agreed by the family members.

This study was approved by the Ethics Committee of Affiliated Hospital of Taishan Medical University. Patients who participated in this research had complete clinical data. The signed informed consents were obtained from the patients or the guardians.

The following experimental reagents were used: Fluorescence quantitative polymerase chain reaction (PCR) reagent and ribonucleic acid (RNA) extraction reagent were purchased from Takara and animal cell protein extraction kit was purchased from Thermo Fisher Scientific, Inc. Streptomycin-peroxidase (S-P) kit and corresponding antibodies were purchased from Thermo Fisher Scientific, Inc. Genome extraction kit was purchased from AXYGEN and other reagents and consumables were purchased from Sangon Biotech Co., Ltd.

Methods
-------

### Quantitative PCR

#### RNA extraction

After 5 ml of peripheral blood was drawn from healthy subjects and OSCC patients and centrifuged at 1,000 × g at 4°C for 5 min, RNA was extracted according to the instructions of RNA extraction kit ([@b10-ol-0-0-10526]).

#### Quantitative PCR

To detect the messenger RNA (mRNA) expression of *PTEN* gene in different samples, SYBR-Green 1 staining was performed in accordance with the instructions. The reaction system volume was in total 25 µl, pre-denaturation at 95°C for 5 min, denaturation at 95°C for 30 sec, annealing at 60° for 45 sec, extension at 72°C for 3 min, with 35 cycles, and then extension at 72°C for 5 min. PCR products were stored at 4°C. With GAPDH as the internal control, the relative expression level of miR-204 was calculated by 2^−ΔΔCq^ method ([@b11-ol-0-0-10526]). The sequences are shown in [Table I](#tI-ol-0-0-10526){ref-type="table"}.

#### Western blot analysis

The total protein was extracted from the sample using the AXYGEN animal cell protein extraction kit. According to the instructions 0.5 mg of different research samples were accurately taken and quantified via Coomassie blue staining. After treatment, 20 µl samples were taken for sodium dodecyl sulfate polyacrylamide gel electrophoresis (10%). Then the protein was transferred onto a polyvinylidene difluoride membrane, sealed for 2 h at 4°C. Bull serum albumin (BSA), blocking buffer (5%) was used as the blocking reagent. Then the membrane was incubated with the primary antibody (shown below) at 20°C for 2 h, incubated again with the secondary antibody at room temperature for 2 h, and washed with eluent 5 times (10 min/time). Rabbit monoclonal anti-PTEN antibody (cat. no. ab32199; dil, 1:500); rabbit polyclonal GAPDH antibody (cat. no. ab37168; dil, 1:500) and secondary goat anti-rabbit (HRP) IgG antibody (cat. no. ab6721; dil, 1:2,000) were all purchased from Abcam. Finally, the color was developed using the developing solution.

#### Immunohistochemical assay

In this study, the lesion tissue samples were routinely incubated with the antibody and stained with S-P. The immunohistochemical evaluation criteria were: membrane staining \<10% or negative after staining (negative), and only membrane staining or \>10% (positive) ([@b12-ol-0-0-10526]).

Gene polymorphism detection
---------------------------

### Genome extraction

After 5 ml peripheral blood was drawn from healthy subjects and OSCC patients and centrifuged at 1,000 × g and 4°C for 5 min, and genome was extracted according to the instructions of the kit ([@b13-ol-0-0-10526]).

PCR-restriction fragment length polymorphism (RFLP). The primers used in this study were produced by Sangon Biotech Co., Ltd., and the primer sequences are shown in [Table II](#tII-ol-0-0-10526){ref-type="table"}.

The PCR products obtained were collected and connected according to the gel recovery and T-vector connection operations in the Molecular Cloning Manual, and added with DH5α, followed by colony PCR verification and sequencing.

### Sequencing

In the present study, the *Escherichia coli* transfected with the target plasmid was used as a template for colony PCR verification, and the gene was sent to Sangon Biotech Co., Ltd., for sequencing.

### Statistical analysis

The experimental data in this study were processed and analyzed using Statistical Product and Service Solutions (SPSS) 20.0 software (IBM, Armonk, NY, USA). The test level was α=0.05, P\<0.05 indicates that the difference was significant, and P\<0.01 indicates that the difference was very significant.

Results
=======

### Difference in mRNA expression level of PTEN between healthy subjects and OSCC patients

Whether there was a difference in the PTEN mRNA level between healthy subjects and OSCC patients was detected via quantitative PCR. As shown in [Fig. 1](#f1-ol-0-0-10526){ref-type="fig"}, there was no significant difference in the PTEN mRNA expression level between healthy subjects and OSCC patients (P\>0.05), indicating that the PTEN mRNA level had no difference between healthy subjects and OSCC patients.

### Difference in protein expression level of PTEN between healthy subjects and OSCC patients

The total protein extracted from the blood in healthy subjects and OSCC patients were used as the objects of study, and the difference in PTEN protein expression level in different subjects was detected via western blot analysis. As shown in [Fig. 2](#f2-ol-0-0-10526){ref-type="fig"}, the PTEN protein expression level significantly declined in OSCC patients (2.37±1.01 µg/l)compared with that in healthy subjects (3.09±0.95 µg/l), and there was a significant difference (P\<0.05), indicating that the decrease in the PTEN protein expression level was negatively correlated with OSCC. At the same time, the results of quantitative PCR revealed that PTEN was correlated with OSCC at the protein level, but not at the mRNA level, suggesting that OSCC affects the translation process of *PTEN* gene without affecting its gene transcription process.

### Immunohistochemical detection of PTEN gene between healthy subjects and OSCC patients

The analysis of immunohistochemical results of samples from healthy subjects and OSCC patients showed that the expression level of PTEN in oral cells of healthy subjects was higher than that of OSCC patients. In other words, the proportion of PTEN-positive cells in the total in control group (68%) was significantly higher than that in experimental group (28%), and there was a significant difference (P=0.015 \<0.05), which is consistent with the protein detection results ([Fig. 3](#f3-ol-0-0-10526){ref-type="fig"} and [Table III](#tIII-ol-0-0-10526){ref-type="table"}).

### Determination of rs2943773 genotype of PTEN gene in healthy subjects and OSCC patients

The total DNAs extracted in control and experimental group were used as templates, and then the *PTEN* gene was amplified and sequenced. It was found that there was no significant difference in the rs2943773 genotype between the control and experimental groups (χ^2^=0.863, P=0.712), indicating that the difference in PTEN protein expression between healthy subjects and OSCC patients is not caused by the difference in rs2943773 ([Table IV](#tIV-ol-0-0-10526){ref-type="table"}).

### Determination of rs9651495 genotype of PTEN gene in healthy subjects and OSCC patients

The genome extracted in the control and experimental groups was used as a template, and then the rs9651495 was amplified and sequenced. It was found that there was a significant difference in the rs9651495 genotype between the two groups (P\<0.05) ([Fig. 4](#f4-ol-0-0-10526){ref-type="fig"}). The C/C genotype frequency of rs9651495 in OSCC patients (50.15%) was significantly higher than that in healthy subjects (23.71%), showing a significant difference (P\<0.05). The C/T genotype frequency of rs9651495 had no significant difference between the two groups (18.52 vs. 19.01%) (P\>0.05). The T/T genotype frequency of rs9651495 in OSCC patients (31.33%) was obviously lower than that in healthy subjects (57.19%), displaying a significant difference (P\<0.05), suggesting the correlation between rs9651495 locus polymorphism of *PTEN* gene and OSCC ([Table V](#tV-ol-0-0-10526){ref-type="table"}).

### Detection of correlation between PTEN gene polymorphism and genotype

To explore the correlation between OSCC and PTEN polymorphism, the figure was plotted with the ratio of C/C of rs9651495 in PTEN gene as the abscissa and the presence or absence of OSCC as the ordinate. As shown the proportion of OSCC patients was significantly increased with the increase of C/C ratio ([Table V](#tV-ol-0-0-10526){ref-type="table"}), suggesting that there is a significant correlation between rs9651495 locus polymorphism of PTEN gene and OSCC.

Discussion
==========

The morbidity rate of OSCC, an oral disease seriously harming human health, has shown an increasing trend year by year ([@b14-ol-0-0-10526]--[@b16-ol-0-0-10526]). According to statistical data, the incidence rate of OSCC in China is significantly higher than that in other countries due to large population and different dietary habits ([@b17-ol-0-0-10526],[@b18-ol-0-0-10526]). Therefore, enhancing the research on OSCC has important medical significance. In the present study, OSCC patients treated in the hospital and healthy subjects were selected as the objects to investigate the correlation between OSCC and *PTEN* gene polymorphism. It was found via quantitative PCR that there was no significant difference in the expression level of *PTEN* gene between healthy subjects and OSCC patients (P\>0.05), indicating that OSCC does not inhibit the *PTEN* gene transcription level. Then the PTEN protein expression level was detected in the experimental and control groups via western blot analysis. The results showed that the PTEN protein expression level significantly declined in OSCC patients (2.37±1.01 µg/l) compared with that in healthy subjects (3.09±0.95 µg/l), and there was a significant difference (P\<0.05), indicating that *PTEN* gene is correlated with OSCC. The immunohistochemical results were consistent with the protein detection results, suggesting that OSCC can inhibit the translation process of *PTEN* gene. However, how this process occurs remains unclear ([@b19-ol-0-0-10526],[@b20-ol-0-0-10526]). It is evident through the above experiments that there is a correlation between OSCC and *PTEN* gene, namely, PTEN expression is low in OSCC patients. Based on these results, the genome extracted from healthy subjects and OSCC patients was used as a template, and then the different regions of the *PTEN* gene were amplified and sequenced. It was found that there was a significant difference in the rs9651495 genotype between the control group and experimental group (P\<0.05). The C/C genotype frequency of rs9651495 in OSCC patients (50.15%) was significantly higher than that in healthy subjects (23.71%), showing a significant difference (P\<0.05). The C/T genotype frequency of rs9651495 had no significant difference between the control and experimental groups (18.52 vs. 19.01%) (P\>0.05). The T/T genotype frequency of rs9651495 in OSCC patients (31.33%) was obviously lower than that in healthy subjects (57.19%), displaying a significant difference (P\<0.05). The above results demonstrate that there is a positive correlation between rs9651495 locus polymorphism of *PTEN* gene and OSCC, and OSCC is induced more easily in subjects with higher C/C genotype frequency.

In conclusion, the higher C/C genotype frequency corresponds to the lower PTEN protein expression level, thus inducing OSCC.
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###### 

Primer sequences in quantitative PCR.

  Primers         Sequences
  --------------- ---------------------------
  rs2943773RT-F   ATGCTAGCTGATCGATCAGCTA
  rs2943773RT-R   CGTAGCTAGTATACGTACGCTACG
  rs9651495RT-F   CGTAGCTAGCTAGCATCGATACG
  rs9651495RT-R   CGTAGCTAGCATCGAGGCTACGAGC
  GAPDH-F         CGTAGGGCTAGCTAGCTAGATAC
  GAPDH-R         CGTAGCTGAGAGTTAGCTAGCATC

###### 

Primers in PCR-RFLP.

  Primers       Sequences
  ------------- ----------------------------
  rs2943773-F   ATCGTAGCTAGAGCATCGATCGAC
  rs2943773-R   CGATGCTACGATCGAGACTAGCTA
  rs9651495-F   TGCATCGAGGCGAGCGACTAGATA
  rs9651495-R   GCTAGCATGGAGCAGCGATCAGCATG

###### 

Immunohistochemical results of PTEN gene between healthy people and OSCC patients.

  Groups         Number of positive cells   Ratio of positive cells in the total (%)   Number of negative cells
  -------------- -------------------------- ------------------------------------------ --------------------------
  Control        68/100 cells               68                                         30/100 cells
  Experimental   28/100 cells               28                                         70/100 cells
  P-value                                   0.015 \<0.05                               

P\<0.05, the difference is significant.

###### 

Determination of rs2943773 genotype of PTEN gene in healthy people and OSCC patients.

                 Genotype                      
  -------------- -------------- -------------- --------------
  Control        42.5           38.4           19.1
  Experimental   40.3           35.6           24.1
  P-value        0.327 \>0.05   0.291 \>0.05   0.185 \>0.05

P\<0.05, the difference is significant.

###### 

Determination of rs9651495 genotype of *PTEN* gene in healthy subjects and OSCC patients.

                 Genotype                      
  -------------- -------------- -------------- --------------
  Control        23.71          19.01          57.19
  Experimental   50.15          18.52          31.33
  P-value        0.012 \<0.05   0.129 \>0.05   0.023 \<0.05

P\<0.05, the difference is significant.
